Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
>200 µM
Hemolytic
Cytotoxic
50% Hemolysis | >200 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. | Nat Commun | 2018